Navicare Biotech , Ltd. Total Liabilities

The latest total liabilities for 8472.TWO is $740M as of June 2026. That compares with $780M in the prior-year period — down 5.3% year over year. Investors often review this figure alongside Navicare Biotech , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 8472.TWO's total liabilities moved from $780M to $740M — a 5.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Navicare Biotech , Ltd.'s operating scale or balance-sheet position.

A total liabilities figure of $740M for 8472.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 8472.TWO's total liabilities ($740M), review year-over-year change from $780M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.